The AAPP Foundation continues to proudly support the AAPP Outcomes Initiative with a second $250,000 research grant. This 2025 grant has been awarded to study the impact of care by psychiatric pharmacists on the treatment of depression. The project, “Alternate Prescriber Type - Depression Management (Trial APT-DM): Impact of Psychiatric Pharmacist on Major Depressive Disorder in Primary Care,” will be led by Co-Principal Investigators, Dr. Nathaniel Rickles (UConn School of Pharmacy), Dr. Wilner Samson (Hartford Healthcare), and Dr. Charles Caley (Western New England University College of Pharmacy and Health Sciences). Congratulations to the researchers! And thanks to all psychiatric pharmacists for their work treating patients with depression!